The biotech sector is on pace for its worst weekly decline since December, weighed down in part by uncertainty following this week's surprise announcement from FDA chief Scott Gottlieb that he will be stepping down next month.
The biotech sector is on pace for its worst weekly decline since December, weighed down in part by uncertainty following this week's surprise announcement from Food And Drug Administration Commissioner Scott Gottlieb that he will be stepping down next month.
The widely traded iShares Nasdaq Biotech Index ETF fell by about 1 percent in midday trading Thursday, down about 5 percent over the last three days following Gottlieb's announcement. The large cap, NYSE Arca Biotech Index is down nearly 4 percent since Tuesday. "He seemed to be very sensible in his approach of really pushing for biosimilars… which I think will be critical for the industry to remain viable--costs will be focused on newer drugs, not 20-year old ones,"wrote one respondent.
"I am confident that innovative new gene therapy and cell therapy we've seen get approved, can continue," after Gottlieb leaves, said Yee."The question is whether or not generic approvals could slow down -- whether or not there's an issue there."
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Biotech stocks fall after FDA chief Scott Gottlieb resignsThe IBB, an ETF that tracks biotech's biggest players, was down more than 2 percent Wednesday, on pace for its worst day since February 7 when it lost 2.5 percent.
Consulte Mais informação »
Reynolds tobacco debuts e-cigarette commercial, tightens online vape sales to combat teen useReynolds is also tightening online sales as the FDA weighs e-cigarette regulations.
Consulte Mais informação »
Silicon Valley just lost a friend with the exit of Gottlieb from the FDASilicon Valley's tech companies like Apple and Alphabet had an ally in FDA commissioner Scott Gottlieb.
Consulte Mais informação »
Birth control recall: Pregnancy risk warning issued by FDA after 'packaging error'The FDA warned those using the affected drugs to use alternative precautions to prevent pregnancy.
Consulte Mais informação »
Nasal spray drug related to ketamine approved by FDA to treat depressionThe FDA approved esketamine, an experimental nasal spray that delivers the active ingredients of the “club drug” ketamine, as a new treatment for severe depression.
Consulte Mais informação »
Asbestos found in Claire's cosmetics, FDA saysThe FDA advised consumers not to use three Claire's brand cosmetic products after tests found they contained asbestos
Consulte Mais informação »
Scott Gottlieb, who won praise for trying to do his regulatory job, is quitting the FDAScott Gottlieb, possibly Trump's only effective regulator, announces his departure from the FDA — but what will come of his initiatives? hiltzikm weighs in:
Consulte Mais informação »
FDA finds asbestos in three Claire's cosmetics productsThe U.S. Food and Drug Administration called on Congress to modernize rules for ...
Consulte Mais informação »
FDA approves nasal spray for depressionCNN News, delivered. Select from our newsletters below and enter your email to subscribe.
Consulte Mais informação »